ScImage announced the signing of a major five-year, $25 million global enterprise cardiology contract with a large international healthcare organization. LOS ALTOS ...

Cardiovascular diseases (CVD) remain the leading cause of disease burden, causing one in three deaths worldwide as a result of population growth, population aging and exposure to a broad range of ...

A world without cardiovascular disease (CVD) is possible, yet millions of lives are lost prematurely to heart disease each year, according to the new Global Burden of Disease (GBD) special report ...

I have treated hundreds of ST-elevation myocardial infarctions in the United States. The algorithms for STEMI are second nature: rapid triage, door-to-balloon metrics, cath lab activation, mechanical ...

Women who experience severe bleeding after giving birth face elevated risks to their cardiovascular health that can persist for up to 15 years—a new analysis of data from over 9.7 million women across ...

This is up from a 2023 market size of $1.44 billion, according to an Aug. 5 release by The Business Research Company. Market growth is attributed to an uptick in cardiovascular diseases, the ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the first patient has been dosed in ZENITH (ZilebEsiraN ...

WASHINGTON (September 24, 2025) — Cardiovascular diseases (CVD) remain the leading cause of disease burden , causing one in three deaths worldwide as a result of population growth, population aging ...